Experimental methods to demonstrate the efficacy and safety of Xenaderm™ ointment: A novel formulation for treatment of injured skin due to pressure ulcers

Wounds

Volumn 15, Issue 3 SUPPL., 2003, Pages

  Maas Irslinger, Rainer ^a   Hensby, Christopher N ^a   Farley, Kathleen L ^a  

^a Healthpoint Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BALSAM PERU; CASTOR OIL; DERMATOLOGICAL AGENT; TRYPSIN; UNCLASSIFIED DRUG; WATER; XENADERM;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTACT SENSITIZATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECUBITUS; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG FORMULATION; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; EPITHELIZATION; ERYTHEMA; FEMALE; FOREARM; HEALING; HEALTH STATUS; HUMAN; MALE; NORMAL HUMAN; OINTMENT; PATCH TEST; SKIN BLOOD FLOW; SKIN INJURY; SKIN PROTECTION; SKIN WATER LOSS; STATISTICAL SIGNIFICANCE; TIME; WOUND HEALING;

EID: 0037358051     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cuddigan J, Berlowitz DR, Ayello EA. Pressure ulcers in America: Prevalence, incidence, and implications for the future. An executive summary of the National Pressure Ulcer Advisory Panel monograph. Adv Skin Wound Care 2001;14:208-15.
2. Schoonhoven L, Defloor T, Grypdonck MH. Incidence of pressure ulcers due to surgery. J Clin Nurs 2002;11:479-87.
3. Lyder CH. Perineal dermatitis in the elderly. A critical review of the literature. J Gerontol Nurs 1997;23:5-10.
4. Le Lievre S. The management and prevention of incontinence dermatitis. Br J Community Nurs 2001;6:180-5.
5. Haugen V. Perineal skin care for patients with frequent diarrhea or fecal incontinence. Gastroenterol Nurs 1997;20:87-90.
6. Ratliff CR, Rodeheaver GT. Pressure ulcer assessment and management. Lippincotts Prim Care Pract 1999;3:242-58.
7. Noble TA, Carr DS, Gonzalez MF. Use of a trypsin, Peru balsam, and castor oil spray on the oral mucosa: Case report and review of the literature. Pharmacotherapy 1989;9:386-8.
8. Schindler S, Motta GJ. Study project: The use of a topical circulatory stimulant for the treatment of pressure ulcers. Ost/Wound Manag 1991;32:50-2.
9. Kosiak M, Kubicek WG, Olson M, et al. Evaluation of pressure as a factor in the production of ischial ulcers. Arch Phys Med Rehab 1958;39:623-9.
10. Edsberg LE, Natiella JR, Baier RE, Earle J. Microstructural characteristics of human skin subjected to static versus cyclic pressures. J Rehabil Res Dev 2001;38:477-86.
11. Schubert V, Perbeck L, Schubert PA. Skin microcirculatory and thermal changes in elderly subjects with early stage of pressure sores. Clin Physiol 1994;14:1-13.
12. van Marum RJ, Meijer JH, Ribbe MW. The relationship between pressure ulcers and skin blood flow response after a local cold provocation. Arch Phys Med Rehabil 2002;83:40-3.
13. Sanada H, Nagakawa T, Yamamoto M, et al. The role of skin blood flow in pressure ulcer development during surgery. Adv Wound Care 1997;10:29-34.
14. Wywialowski EF. Tissue perfusion as a key underlying concept of pressure ulcer development and treatment. J Vasc Nurs 1999;17:12-6.